Binuv John News Today

Ursodeoxycholic acid exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2 infection.

MONDAY, April 10, 2023 (HealthDay News) -- Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 severity in patients with

Cirrhosis of the liver is associated with decreased responsiveness to many vaccines, including those that protect against COVID-19.

Among cirrhosis patients, receiving a third dose of the vaccine was associated with an 80 per cent reduction in overall Covid-19 and a 100 per cent reduction in the severe course of the infection or death, says a new report.The study, published ...

SAN DIEGO — Vaccine-induced immunity correlated with significantly greater protection against COVID-19 compared with infection-induced immunity in patients with cirrhosis, according to results presented at Digestive Disease Week 2022. “Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be infection- or vaccine-induced,” Binu V. John, MD, MPH, affiliate

Despite offering somewhat less protection than in other populations, vaccinated cirrhosis patients still experienced a 100% reduction in hospitalization and death compared with unvaccinated peers.

COVID-19 vaccine offers lesser, delayed protection against infection in people with cirrhosis A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population. Before this research, published July 13 in JAMA Internal Medicine, how much ...